Thanks for the vid link, he'd be much happier had he gone with Roche and the drug had been marketed, sold, and distributed worldwide as the number 1 influenza drug it should be/is.
Then the law suit debarkle with GSK.
Fingers crossed he/they get it right with Lani this time, effectively doubling the income and outlook short/med term. This is the news we await that will surge the SP to those all time highs and double figures.
Add to My Watchlist
What is My Watchlist?